Growing Gene & Cell Therapy Cooperative Seeks Applications for Clinical Trial Support

Growing Gene & Cell Therapy Cooperative Seeks Applications for Clinical Trial Support

The GGACT cooperative, a collaboration between Boston Children’s Hospital, Cincinnati Children’s Hospital Medical Center, and the University of California Los Angeles, was established to support investigators in rapidly translating complex gene and cell therapies to early phase, investigator-initiated clinical trials by providing expertise in protocol development and implementation, trial and data management, and regulatory affairs, as well as utilizing established infrastructure for preclinical models of disease and testing, process development, and GMP vector production and cellular manufacturing. More information on the GGACT can be found on www.GGACT.org.

Eligible applicants must be faculty at a CTSA institution that has an established pediatric stem cell transplant program. See the attached RFA for further details.

Letters of Intent should be submitted to Maria Suarez at maria.suarez@childrens.harvard.edu no later than Monday, July 2, 2018.

Invited, full applications will be due by September 21, 2018.

Bryan Belmer
bbelmer@mcw.edu


NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.

PARTNERS

Zablocki VA Medical CenterMedical College of WisconsinMSOE